Vaccinex, Inc. Shareholders' Equity
Vaccinex, Inc. (VCNX) had Shareholders' Equity of $7.41 million as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-03-31
- 2021-12-31: Stockholders' Equity Attributable to Parent $7.41M.
- 2021-09-30: Stockholders' Equity Attributable to Parent $11.89M.
- 2021-06-30: Stockholders' Equity Attributable to Parent $16.94M.
- 2021-03-31: Stockholders' Equity Attributable to Parent $818.00K.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2021-12-31 | $7.41M 10-K · filed 2022-03-31 |
| 2021-09-30 | $11.89M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $16.94M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $818.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$26.57M 10-K · filed 2022-03-31 |
| 2020-09-30 | -$20.20M 10-Q · filed 2020-11-13 |
| 2020-06-30 | -$29.54M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$25.70M 10-Q · filed 2020-05-14 |
| 2019-12-31 | -$26.24M 10-K · filed 2021-03-31 |
| 2019-09-30 | -$20.05M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$26.34M 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$17.63M 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$8.62M 10-K · filed 2020-03-09 |
| 2018-09-30 | -$218.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | -$139.83M 10-Q · filed 2018-08-14 |
| 2017-12-31 | -$125.45M 10-K · filed 2019-03-13 |